Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment
James Lomas,
Jessica Ochalek,
Rita Faria
Applied Health Economics and Health Policy,
vol. 20, 2022, p. 13-18.
A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials.
Rita Faria,
Manuel Gomes,
David Epstein,
Ian White
Pharmacoeconomics,
vol. 32, 2014, p. 1157-1170.